Zimmer Biomet Holdings Inc

ZBH

Market Cap$26.2B

Close$

Compare Zimmer Biomet Holdings

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Zimmer Biomet Holdings Inc	25.6	0.75%	8%	3.5	0.5
Market Avg	59.7	1.27%	30%	-	0.9
Healthcare Avg	64.5	1.29%	15%	7.1	0.8

$76.93

Current Fair Value

38% downside

Overvalued by 38% based on the discounted cash flow analysis.

Share Statistics

Market cap	$26.20 Billion
Enterprise Value	$31.55 Billion
Dividend Yield	$0.9572 (0.75%)
Earnings per Share	$4.88
Beta	0.66
Outstanding Shares	205,461,451
Avg 30 Day Volume	1,187,514

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	25.59
PEG	-6.08
Price to Sales	3.54
Price to Book Ratio	2.07
Enterprise Value to Revenue	4.27
Enterprise Value to EBIT	21.74
Enterprise Value to Net Income	30
Total Debt to Enterprise	0.18
Debt to Equity	0.46

Revenue Sources

No data

ESG Score

No data

About Zimmer Biomet Holdings Inc

CEO: Bryan Hanson